8-KItem 8.01 · Other Events
ResMed starts $450 million accelerated share repurchase with Citibank
Filed with the SEC on · Summarized by InvestorsBot
ResMed entered into an accelerated share repurchase agreement with Citibank on August 31, 2026, and will pay $450 million on September 3, funded by proceeds from the sale of its MatrixCare business and cash on hand. Citibank is expected to initially deliver shares worth 80% of the payment based on ResMed’s September 2 closing price, with the final share count determined by the average volume-weighted share price; settlement is scheduled for December 2026.